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Preimplantation mammalian embryos in culture secrete autocrine growth factors into the surrounding medium that, in
turn, stimulate the development of the embryos. The full complement of these factors is unknown. Since one hallmark of
embryo development is the formation of an epithelium, the trophectoderm, we tested the hypothesis that one such
embryo-derived growth factor is acrogranin (epithelin/granulin precursor), a factor that possesses growth-regulatory
activities principally toward epithelial cells. We found that acrogranin mRNA was expressed in preimplantation mouse
embryos with the transcript levels rising to their highest point in blastocysts, coincident with the appearance of the
trophectoderm. Indirect immunofluorescence confocal microscopy of preimplantation mouse embryos at different devel-
opmental stages revealed that acrogranin immunostaining was most concentrated in the trophectoderm of blastocysts.
Immunoblotting and immunoprecipitation experiments demonstrated that the embryos secreted acrogranin into the
surrounding medium. To determine how altering the levels of acrogranin in the culture medium surrounding the embryos
might affect embryonic growth and development, acrogranin protein levels in the culture medium were decreased with a
function-blocking antibody or increased by adding the purified acrogranin to the medium. In both a concentration-
dependent and a reversible manner, affinity-purified anti-acrogranin antibody significantly inhibited the development of
eight-cell embryos to the blastocyst stage compared to controls (no added immunoglobulin or nonspecific IgG). Further-
more, embryo cell numbers were significantly decreased in the presence of the highest concentrations of acrogranin
antibody compared to control embryos. Exogenous acrogranin added to cultures of eight-cell embryos accelerated the time
for the onset of cavitation, as well as stimulating the rate of blastocoel expansion and increasing the number of
trophectoderm cells compared to controls. These results indicate that acrogranin can regulate the appearance of the
epithelium in the developing mouse blastocyst, the growth of the trophectoderm, and/or the function of the embryonic
epithelium. © 2000 Academic Presst
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1INTRODUCTION
The blastocyst consists of two cell types: the inner cell
mass (ICM) and the trophectoderm. The ICM is the precur-
sor of the embryo proper while the trophectoderm, a fluid-
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406ransporting epithelial cell layer encasing the embryo, is the
rst differentiated embryonic cell type and subsequently
ives rise to the placenta. Blastocyst formation entails cell
ivision, differentiation, and apoptosis that occur in a
oordinated fashion (Fleming and Johnson, 1988). The pre-
mplantation embryo expresses a variety of peptide growth
actors that likely regulate each of these processes (Kaye,
997). For example, TGF-a can both stimulate the rate of
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407Preimplantation Embryo Development and Acrograninblastocoel expansion and serve as a cell survival factor for
ICM cells (Brison and Schultz, 1998; Dardik and Schultz,
1991a). Little is known, however, regarding the role of
peptide growth factors in epithelial development in the
preimplantation embryo.
A potential candidate for such a function is acrogranin, a
factor that regulates epithelial cell growth and is highly
expressed in tissues of the reproductive tract (Baba et al.,
1993; Shoyab et al., 1990). One of our laboratories originally
isolated and characterized acrogranin as a 67,000 Mr glyco-
protein (Anakwe and Gerton, 1990). The sequence of guinea
pig and mouse testis cDNAs encoding acrogranin demon-
strated that this protein is synonymous with the precursor
of the epithelin and granulin peptides (Baba et al., 1993;
Bateman et al., 1990; Shoyab et al., 1990). Acrogranin
mRNA is ubiquitously expressed in a variety of human,
mouse, and guinea pig tissues (Baba et al., 1993; Bhandari et
al., 1993; Plowman et al., 1992). Interestingly, acrogranin
mRNA and protein are most highly expressed in the testis,
kidney, epididymis, vas deferens, seminal vesicles, ovary,
uterus, and lung, suggesting that acrogranin plays a role in
reproduction.
Acrogranin and its derivatives (epithelins, granulins,
transforming growth factor e, and others) are regulators of
cell growth. Epithelins 1 and 2 (;6000 Mr) were originally
purified from rat kidney extracts (Shoyab et al., 1990).
Epithelin 1 stimulates the proliferation of murine keratin-
ocytes in culture, whereas epithelin 2 inhibits the action of
epithelin 1. In contrast, both epithelin 1 and epithelin 2
inhibit the growth of the epidermoid carcinoma A431 cells
and the proliferation of the human breast carcinoma cell
line MDA-MB-468 (Culouscou et al., 1993; Shoyab et al.,
1990). The granulins isolated from human leukocytes and
rat bone marrow are structurally related to epithelins and
are derived from the same precursor, acrogranin (Bateman
et al., 1990). Granulins have also been identified in fish
(Belcourt et al., 1993, 1995) and recently have been isolated
from human urine (Sparro et al., 1997). A larger fragment of
acrogranin (23,000–25,000 Mr), termed transforming
rowth factor e (for epithelium), is an autostimulatory
ransforming growth factor required for the optimal growth
f SW-13 adrenal carcinoma cells in soft agar (Halper and
oses, 1987; Parnell et al., 1992). More recently, the
ull-length acrogranin protein has been demonstrated to be
n autocrine growth regulator for a highly tumorigenic cell
ine (Zhou et al., 1993) and for a 3T3 cell line null for the
ype 1 insulin-like growth factor receptor (Xu et al., 1998).
As a consequence of the high expression of acrogranin in
eproductive tissues, as well as recognizing that the first
ign of cellular differentiation in the preimplantation mam-
alian embryo is the formation of the initial epithelium,
he trophectoderm, we tested the hypothesis that acrogra-
in regulates blastocyst formation with the concomitant
ormation of the trophectoderm. We report that (1) acrogra-
in mRNA and protein are expressed in the preimplanta-
ion mouse embryo (with the levels rising to highest
mount at the blastocyst stage), (2) acrogranin is secreted
Copyright © 2000 by Academic Press. All rightnto the culture medium by blastocysts, (3) a function
nhibiting anti-acrogranin antibody reversibly inhibits de-
elopment of eight-cell embryos to the blastocyst stage, and
4) addition of acrogranin to the culture medium stimulates
lastocyst formation.
MATERIALS AND METHODS
Oocyte and Embryo Collection and Culture
Female mice (CF-1, 6 weeks of age; Harlan Industries, Indianap-
olis, IN) were injected with 5 IU of pregnant mare serum gonado-
tropin (PMSG) and, 48 h later, with 5 IU of human chorionic
gonadotropin. The medium for collection of oocytes and embryos
was bicarbonate-free minimal essential medium (Earl’s salts)
supplemented with polyvinylpyrrolidone (3 mg/ml), pyruvate (100
mg/ml), gentamicin (10 mg/ml), and 25 mM 4-(2-hydroxyethyl)-1-
iperazine ethanesulfonic acid (Hepes), pH 7.2 (MEM/PVP) (Manej-
ala et al., 1986). Fully grown mouse oocytes were obtained from
MSG-primed females and freed of attached cumulus cells; to
nhibit the resumption of meiosis, 0.2 mM 3-isobutyl-1-
ethylxanthine was present in the collection medium. For embryo
ollection, females were paired with B6D2F1/J males (The Jackson
aboratory, Bar Harbor, ME). At appropriate times following mat-
ng, one-cell, two-cell, four-cell, eight-cell, morula, and blastocyst
tage embryos were flushed from the excised reproductive tracts
nto bicarbonate-free MEM/PVP. The embryos were cultured at
7°C in 50 ml of KSOM medium (Erbach et al., 1994) under mineral
oil in a humidified atmosphere of 5% CO2 in air.
Oocyte and Embryo RNA Preparation and
Semiquantitative RT-PCR Assay
The preparation of RNA from oocytes and embryos and reverse
transcription were performed as described previously (Temeles et
l., 1994). Prior to the isolation of RNA, 0.125 pg of rabbit globin
RNA (BRL) was added per embryo; this RNA serves as a standard
o normalize the differences in RNA recovery and efficiency of the
T-PCR procedures. Oligo(dT)-primed reverse transcription was
onducted on 100 oocyte and embryo equivalents. The polymerase
hain reactions were performed in 100 ml of 10 mM Tris–HCl, pH
8.3, containing 50 mM KCl, 1.45 mM MgCl2, the four dNTPs at 0.2
M each, 5 mCi [a-32P]dCTP (sp act 3000 Ci/mmol; Amersham),
.5 units AmpliTaq polymerase, 20 pmol (0.4 mM) each of appro-
priate 39 and 59 primers, and a volume of the reverse transcription
reaction. For acrogranin, the forward primer was CGAAAGAA-
GATTCCTCGCTGGGAC, corresponding to nucleotides 1732–
1755 of pMG1, and the reverse primer was AGAACACCTGTG-
GCTCGGGAAGAG, corresponding to nucleotides 2039–2062 of
pMG1 (Baba et al., 1993). The basic PCR program was a 95°C soak
for 1 min, followed by a cycle program of 95°C for 10 s, then 60°C
for 15 s. Following PCR, the tubes were chilled briefly on ice and
centrifuged to collect any condensation. Then 25-ml aliquots were
removed and treated with 2 ml of a 20 mg/ml solution of RNase for
10 min at room temperature to digest any remaining carrier RNA.
After the addition of 5 ml of 63 loading buffer (0.25% bromophenol
blue in 40% sucrose), 13-ml aliquots of each sample were subjected
to electrophoresis on a 4% agarose gel (Manejwala et al., 1991). The
bands were located under UV light and excised with a razor blade.
The incorporation of radiolabeled deoxycytidine triphosphate
(dCTP) in each gel slice was determined by Cerenkov counting.
s of reproduction in any form reserved.
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408 Dı´az-Cueto et al.Immunofluorescence and Laser-Scanning Confocal
Microscopy
Oocytes and embryos were collected and the zonae pellucidae
were removed with acid Tyrode’s solution (Bornslaeger and
Schultz, 1985). The zona pellucida-free oocytes or embryos were
analyzed by indirect immunofluorescence and laser-scanning con-
focal microscopy as described previously (Stein et al., 1997). The
primary antibody was rabbit anti-acrogranin (Anakwe and Gerton,
1990). Controls for indirect immunofluorescence experiments in-
cluded the use of preimmune serum as the primary serum and the
omission of the primary serum (secondary antibody alone).
Metabolic Labeling of Mouse Embryos and
Spermatogenic Cells with [35S]Cysteine and
Immunoprecipitation of Acrogranin
Mouse embryos. Early cavitating blastocysts (500) were col-
lected and incubated in the presence of 50 mCi [35S]cysteine (sp act
;1075 Ci/mmol; New England Nuclear (NEN), Boston, MA) in a
50-ml drop of KSOM medium without albumin or added amino
acids. Cysteine was used as the radiolabeled precursor because
approximately 15% of the amino acids in acrogranin are cysteine
(Baba et al., 1993). The embryos were then incubated for 12 h at
37°C under a 95% air:5% CO2 atmosphere. The resulting “condi-
tioned medium” containing secreted 35S-radiolabeled proteins was
ecovered by aspiration. Embryos and conditioned medium were
tored at 270°C prior to being subjected to immunoprecipitation.
Spermatogenic cells. A mixed population of guinea pig
achytene spermatocytes, round spermatids, and condensing sper-
atids was suspended in cysteine-free germ cell minimal essential
edium consisting of Eagle’s minimal essential medium with
arle’s salts supplemented with 100 mg/ml penicillin, 100 mg/ml
streptomycin, 6 mM lactate, 1 mM pyruvate, and 15 mM Hepes
(Gerton and Millette, 1984). A suspension of 8 3 106 cells in 5 ml
as added to 60-mm plastic dishes. [35S]Cysteine (sp act ;1075
Ci/mmol; NEN) was added to a final concentration of 50 mCi/ml.
he cells were incubated for 12 h in a humidified incubator at 33°C
nd 95% air:5% CO2.
Immunoprecipitation. After the embryos and cells were lysed
ith PBS containing 1% sodium cholate, 0.1% SDS, 0.02% sodium
zide, 40 mg/ml aprotinin, 40 mg/ml leupeptin, and 4 mM
-aminobenzamidine, PMSF dissolved in ethanol was added to a
nal concentration of 10 mM. Immunoprecipitations were then
erformed using rabbit anti-acrogranin as the primary antibody
Anakwe and Gerton, 1990). The immunoprecipitates were ana-
yzed by sodium dodecyl sulfate–polyacrylamide gel electrophore-
is (SDS–PAGE) using the procedure of Laemmli (1970). After
DS–PAGE, the gels were fixed in 50% methanol and dried.
adioactivity was detected by phosphorimaging using the Storm
ystem (Molecular Dynamics, Sunnyvale, CA). Immunoblotting
as carried out as previously outlined with antibody to acrogranin
Anakwe and Gerton, 1990) using enhanced chemifluorescence and
etection with the Storm System.
Acrogranin Purification
Acid extraction. The purification of acrogranin was performed
using a modification of the procedure described by Anakwe and
Gerton (1990). Guinea pig testes were separated from the tunicae
albugineae and homogenized for 30 s in an extraction buffer made
up of 1 mM HCl (pH 3.0) plus 5 mM benzamidine. The ratio of the
Copyright © 2000 by Academic Press. All righttestes to the buffer was 1:2 (w/v). The homogenate was stirred for
1 h at 4°C. Following centrifugation at 10,000g for 30 min, the
supernatant was collected and adjusted to pH 6.0 with 1 N NaOH.
The precipitate formed was removed by centrifugation. The super-
natant was adjusted to pH 3.0 with 1 M HCl and dialyzed against
several changes of extraction buffer for over 35 h. The sample was
frozen in aliquots and stored at 270°C until used.
Sephacryl S-200 column chromatography. The acid extract of
testes (180 mg of protein in 50 ml) was loaded on a Sephacryl -S-200
column (4.8 3 60 cm) equilibrated in 0.05 M sodium acetate and 0.2
M NaCl, pH 3.5. Proteins were eluted in 18-ml fractions at a flow
rate of 30 ml/h while absorbance was monitored at 280 nm.
Fractions containing acrogranin (as detected by immunoblotting)
were pooled.
Affinity chromatography on a concanavalin A–Sepharose col-
umn. To the pooled material from the Sephacryl S-200 column,
m-aminobenzamidine was added to a final concentration of 0.5
mM. The pH was adjusted to 7.4 and the sample was applied to a
concanavalin A–Sepharose column (2.5 3 13 cm) that had been
equilibrated with 0.5 M NaCl, 0.02 M Tris–HCl, pH 7.4, and 0.5
mM m-aminobenzamidine. The concanavalin A-binding proteins
were eluted with 0.5 M of a-methyl-D-mannopyranoside dissolved
n the same buffer. The eluate was immediately concentrated in an
micon ultrafiltration cell fitted with a YM30 membrane and then
ried in a Jouan Concentrator System (Jouan, Inc., Winchester, VA).
Ion-exchange chromatography. The pooled material from the
receding step was diluted in 5 ml of 0.02 M imidazole, pH 7.0, and
un on a Millipore ConSep LC 100 System, using a HiTrap-Q 5 3
-ml column (Pharmacia Biotech). The column was eluted with a
radient 0 to 1 M NaCl in 0.02 M imidazole, pH 7.0. Fractions
xhibiting only acrogranin were pooled, dialyzed to remove salt,
nd lyophilized prior to resuspension and testing on embryos. A
ingle band of 67,000 Mr was detected in the final product.
Embryo Collection and Culture in the Presence of
Antibody or Acrogranin
Eight-cell embryos were collected about 68 h post-hCG from
superovulated CF-1 female mice mated to B6D2F1/J males as
described above. The embryos were placed in 20-ml drops of KSOM
medium containing essential and nonessential amino acids (Gibco
BRL, Grand Island, NY) (Ho et al., 1995) and incubated under
mineral oil (Sigma) at 37°C in a humidified atmosphere containing
5% CO2. Four different concentrations of affinity-purified anti-
acrogranin antibody (0.03, 0.15, 0.30, and 0.60 mM) were tested.
Medium alone and nonspecific rabbit IgG (0.60 mM) were used as
ontrols. Each experimental group consisted of 20 embryos in 20-ml
rops. The embryos were incubated under oil for 47 h at 37°C in an
tmosphere containing 5% CO2. They were then scored for the
onset of cavitation at 88 and 115 h post-hCG. In other culture
groups, the embryos were removed from the antibody after 14 h,
washed through several drops of medium, and then cultured in
fresh drops of antibody-free medium for another 33 h. These
embryos were scored for the incidence of cavitation at 82, 88, 96,
and 115 h post-hCG.
Three different concentrations of purified acrogranin (0.01, 0.02,
and 0.05 mM) were tested for effects on embryo growth and
development. Medium alone was used as a control. Each experi-
mental group consisted of 20 embryos in 20-ml drops of KSOM
medium containing essential and nonessential amino acids (Ho et
al., 1995). The embryos were incubated under oil at 37°C in an
atmosphere containing 5% CO2. Starting at 45 h, the embryos were
s of reproduction in any form reserved.
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409Preimplantation Embryo Development and Acrograninscored for the onset of cavitation every 4 h until 96 h and, finally,
at 110 h post-hCG.
Differential Labeling of the Inner Cell Mass and
Trophectoderm
The nuclei of blastocyst trophectoderm and ICM cells were
differentially labeled with polynucleotide-specific fluorochromes
following a modification of the “immunodissection” procedure of
Handyside and Hunter (1984). Briefly, the zonae pellucidae were
removed in acid Tyrode’s solution and zona-free blastocysts were
washed in medium M2 containing 5% BSA. The embryos were
then incubated with 10% anti-mouse T-cell antiserum (Thy–1;
Accurate Chemical and Scientific Corp., Westbury, NY) for 10 min
at 37°C. After washing in M2, blastocysts were incubated in a 1:10
dilution of guinea pig complement (Sigma) in M2 containing 40
mg/ml bisbenzimide (Hoechst 33258) and 20 mg/ml propidium
odide. Labeled blastocysts were washed several times in M2 plus
% BSA. Embryos with labeled nuclei were individually mounted
n microscope slides. ICM nuclei that were labeled with bisben-
imide appeared blue and trophectoderm nuclei that were labeled
ith the combination of propidium iodide and bisbenzimide ap-
eared pink. After photography and recording of the staining
attern, the embryos were carefully squashed and disaggregated by
ently pressing the coverslip with a pencil eraser; the slide was
hen examined again for counting.
Measurement of Blastocoel Expansion
The rate of increase in the volume of the blastocoel was
measured as described previously (Manejwala et al., 1986). The
nascent cavities of the embryos were measured and then the
embryos were placed in individual drops of medium alone or
medium containing acrogranin. The axes of the blastocoels of
individual embryos were measured as a function of time on an
inverted microscope at 200-fold magnification; the focal plane was
adjusted to measure the long and short axes of the cavity, and the
volume of the blastocoel was calculated assuming a prolate spher-
oid shape (V 5 (4/3)pab2). For some experiments the initial volume
of a blastocoel was subtracted from the size of the cavity at a later
time point to yield the relative change in blastocoel volume.
Statistical Analysis
One-way analysis of variance was employed to determine differ-
ences between groups. When differences existed, the t test was used
to determine which means were significantly different. A value of
P , 0.05 was considered statistically significant. The JMP version
3 statistical package was used for all analyses.
RESULTS
Expression of Acrogranin mRNA from the
Embryonic Genome during Preimplantation
Embryo Development Precedes the Formation
of the Trophectoderm
The expression of the acrogranin mRNA in the preim-
plantation mouse embryo was examined using a semiquan-
titative RT-PCR assay (Fig. 1). By arbitrarily setting the
Copyright © 2000 by Academic Press. All rightignal from blastocyst as 100 units, we found that the
elative level of acrogranin mRNA started at about 80–85
nits in oocytes, dropped below 75 units in eggs, continued
o decline to ;60 units in one-cell zygotes, and then
ropped precipitously to the ;7 unit level in two-cell
embryos. The signal then returned to the ;80 unit level by
the eight-cell stage, which precedes the morula stage and
subsequent blastocyst stage (100 unit level) when the epi-
thelium is first formed. This pattern of expression is typical
of many genes that are expressed in the preimplantation
embryo and reflects the replacement of maternal mRNAs
with embryonically expressed transcripts (Schultz, 1993).
Acrogranin Protein Expression during
Preimplantation Embryo Development Suggests
an Apical Secretion Pattern
Acrogranin expression and localization in preimplanta-
tion embryos at different developmental stages were exam-
ined by indirect immunofluorescence using the anti-
acrogranin antibody (Fig. 2). Acrogranin immunostaining
was detected in oocytes and appeared progressively fainter
and disappeared in the subsequent stages two, four, and
eight cell). The immunofluorescence signal then reappeared
in morula stage and became much stronger in the apical
surface of the trophectoderm and, to a lesser extent, the
inner cell mass of blastocysts (Fig. 2). The expression
patterns in the various embryo stages correlated with the
RT-PCR data. Neither control (preimmune serum as the
primary serum or secondary antibody alone) resulted in any
FIG. 1. Expression of acrogranin in the preimplantation mouse
embryo as determined by RT-PCR. Left: Ethidium bromide-stained
gel. (A) Amplicons from acrogranin primers. (B) Amplicons from
a-globin primers (exogenously added control). Right: Ratio of
32P-labeled amplicons. (C) Using the signal from blastocyst as
100%, the relative level of acrogranin started at about 80–85% in
oocytes, dropped below 75% in eggs, continued to decline to ;60%
in one-cell zygotes, and then dropped to ;7% in two-cell embryos.
At the eight-cell stage the signal returned to the 80% level and
finally to the 100% level at the blastocyst stage. This experiment
was performed twice with similar results. The values from one
experiment are shown.appreciable staining of the embryos (data not shown).
s of reproduction in any form reserved.
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410 Dı´az-Cueto et al.Mouse Blastocysts Secrete Acrogranin into the
Culture Medium
The immunofluorescence staining in the outer periphery
of the trophectoderm suggested that acrogranin might be
secreted into the medium surrounding the embryos. To test
this possibility, conditioned medium was collected from
blastocysts after a 12-h culture period. The secreted pro-
teins were separated by SDS–PAGE and analyzed by immu-
noblotting using the anti-acrogranin antibody. An immu-
noreactive band with an Mr 67,000 was detected in the
ulture medium (Fig. 3A); the size of the polypeptide was
onsistent with our previous results with guinea pig sper-
atogenic cells (Anakwe and Gerton, 1990).
To verify that blastocysts were capable of synthesizing
nd secreting acrogranin into the medium, blastocysts were
ultured in the presence of [35S]cysteine and the metaboli-
ally radiolabeled, conditioned medium was collected after
2 h. The radiolabeled secreted proteins were used for the
mmunoprecipitation of acrogranin. The antibody specifi-
ally immunoprecipitated acrogranin as a single band of
FIG. 2. Localization of acrogranin in the preimplantation mouse e
progressively fainter, and disappeared in the subsequent embryos s
and became much stronger in the apical surface of the trophectoder
staining in the inner cell mass of the blastocyst. ICM, inner cell m
were performed twice with identical results.rotein with Mr 67,000 from conditioned medium and
Copyright © 2000 by Academic Press. All rightblastocysts, as well as from the guinea pig spermatogenic
cells that were used as positive controls (Fig. 3B). Preim-
mune antiserum failed to immunoprecipitate any radiola-
beled proteins from blastocyst-conditioned medium or the
guinea pig spermatogenic cell extract, demonstrating the
specificity of the protocol. Although background bands
were seen with preimmune serum in the precipitates of
blastocysts, no band comigrated with the authentic acro-
granin. These results indicate that the embryos synthesized
acrogranin and secreted it into the extracellular milieu
surrounding the blastocysts.
Anti-acrogranin Inhibits Blastocyst Formation
The previous set of experiments demonstrated that the
embryos secrete acrogranin into the culture medium. To
test whether the acrogranin could act as autocrine regulator
of the embryo growth and/or differentiation, the effect of
the function-blocking anti-acrogranin antibody on embryo
development was determined. Compacted eight-cell mouse
embryos were cultured in the presence in four different
os. Acrogranin immunostaining was detected in oocytes, appeared
(one, two, and four cell), but then reappeared in the morula stage
lthough not apparent in this micrograph, we occasionally detected
cavity, blastocoelic cavity. The immunofluorescence experimentsmbry
tages
m. A
ass;concentrations of affinity-purified anti-acrogranin antibody
s of reproduction in any form reserved.
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411Preimplantation Embryo Development and Acrogranin(0.03, 0.15, 0.30, and 0.60 mM), medium alone, or nonspe-
ific IgG for 47 h (Fig. 4) and scored for the onset of
avitation at 88 and 115 h post-hCG. Subsequently, the
umber of cells per embryo was determined. In other groups
f embryos, the embryos were cultured for 14 h, washed,
nd transferred to antibody-free medium. After being cul-
ured for another 33 h, the embryos were then scored for the
ncidence of cavitation at 82, 88, 96, and 115 h post-hCG
Fig. 5).
In six experiments, we consistently observed that
ffinity-purified anti-acrogranin antibody significantly (P ,
FIG. 3. Detection of secreted acrogranin in blastocyst-conditione
band by mouse blastocysts into the culture after 12 h in culture. A
Immunoprecipitation of acrogranin. Mouse blastocysts were metab
of acrogranin at 67,000 Mr (triangle) was immunoprecipitated from b
cells used as a positive control. This experiment was performed tw
(3103) of standard proteins.
FIG. 4. Inhibition of cavitation by anti-acrogranin. Mouse embry
n medium alone, with nonspecific IgG, and with four different
ultured for 47 h and scored for cavitation at 88 and 115 h post-hC
nd 0.60 mM) inhibited the development of the embryos in signifi
nonspecific IgG). The data are expressed as means 6 SEM from six e
if no error bars are shown for a given point, the SEM was smaller than
Copyright © 2000 by Academic Press. All right.05) inhibited the development of compacted, eight-cell
mbryos to the blastocyst stage in a dose-dependent manner
Figs. 4 and 6). Controls (no added IgG or nonspecific rabbit
gG) were unaffected. After 20 and 47 h of culture, the
ercentages of embryos that cavitated at 88 and 115 h
ost-hCG were greatly decreased in those groups of em-
ryos treated with the high concentrations of anti-
crogranin antibody compared to controls (no added IgG
nd nonspecific rabbit IgG) (Fig. 4). This inhibitory effect
as reversible; when the antibody was removed by wash-
ng, the treated embryos (with the four doses) progressively
dium. (A) Immunoblot analysis of acrogranin secretion as a single
tract of guinea pig (GP) sperm was used as a positive control. (B)
lly labeled overnight with [35S]cysteine (50 mCi/ml). A single band
cysts, embryo-conditioned medium, and guinea pig spermatogenic
ith similar results. Numbers to the left refer to molecular weights
ere cultured from the eight-cell stage through the blastocyst stage
of affinity-purified anti-acrogranin antibody. The embryos were
he three high concentrations of acrogranin antibody (0.15, 0.030,
form (P , 0.05) compared with the controls (medium alone and
ments. In this and subsequent graphs, error bars represent the SEM;d me
n ex
olica
lasto
ice wos w
doses
G. T
cant
xperi
the size of the symbol.
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412 Dı´az-Cueto et al.cavitated, such that by 115 h post-hCG there were no
significant differences in the percentage of cavitating em-
bryos compared to the controls (Fig. 5). We also noted that
FIG. 5. Reversibility of the effect of anti-acrogranin antibody on
cavitation. Mouse embryos were cultured from the compacted eight-
cell stage through the blastocyst stage in medium alone, with non-
specific IgG, and with four different doses of affinity-purified anti-
acrogranin antibody. Following 14 h of culture, the extent of
cavitation at 88 h post-hCG was greatly decreased in embryos treated
with anti-acrogranin antibody (0.15, 0.30, and 0.60 mM) compared
with the controls (medium and nonspecific IgG). When the antibody
was removed by washing, the treated embryos cavitated and there
were no significant differences in the percentage of cavitating em-
bryos between the groups. The data are expressed as means 6 SEM
from four experiments with 15–20 embryos per data point for each
experiment.
FIG. 6. Morphology of embryos after treatment with anti-acro
post-hCG) with (A) medium alone, (B) medium with nonspecific Ig
he morphology of the nonspecific IgG-treated embryos did not diff
mbryos displayed minimal cavitation. The experiment was performed
Copyright © 2000 by Academic Press. All righthe embryos cultured in medium alone exhibited a pause in
he development of cavities following the washing. This
elay is consistent with the removal of endogenously se-
reted acrogranin from the embryo-conditioned medium
uring this step. Cavitation presumably resumed once the
crogranin (and/or other growth factors) secreted by the
mbryos reached a threshold level.
The antibody-treated embryos were able to escape from
he zonae pellucidae but hatching was delayed by approxi-
ately 14 h compared to the control (medium alone) (Fig.
). The reversible nature of the antibody minimizes the
ikelihood that the antibody has a direct toxic effect on the
mbryos. Consistent with this conclusion is the finding
hat vital dye staining of the embryos cultured in the
resence of the anti-acrogranin antibody did not detect an
ncrease in the incidence of dead or dying cells (data not
hown).
The embryos that did not cavitate were clearly smaller
han those cultured in medium alone or nonspecific IgG
Fig. 6). The smaller sizes could simply result from a
educed ability of the treated embryos to pump fluid into or
aintain fluid within nascent blastocoelic cavities. An-
ther possibility was that the treated embryos consisted of
ewer cells. To examine this question, we recovered eight-
ell embryos at 67 h post-hCG and cultured these for 48 h
n the presence of anti-acrogranin antibody. The number of
ells per embryo was determined after staining the nuclei
ith bisbenzimide. Under these conditions, blastocysts
evelop quite readily in the control group (medium or
onspecific IgG treated). Interestingly, there was a dose-
n. Preimplantation mouse embryos after 28 h in culture (96 h
60 mM), and (C) medium with anti-acrogranin antibody (0.60 mM).
m that of the control embryos although the anti-acrogranin treatedgrani
G (0.
er frofour times; representative images are shown.
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number of cells per embryo cultured in the presence of
increasing concentrations of anti-acrogranin antibody (Fig.
8). These results indicate that the acrogranin secreted by
the embryos acted as an autocrine regulator of cell differ-
entiation (blastocoel formation) and cell proliferation.
Purified Acrogranin Stimulates Blastocoelic Cavity
Formation and Expansion
Since the anti-acrogranin antibody inhibited blastocyst
formation, we hypothesized that the addition of purified
acrogranin would stimulate blastocyst formation. To deter-
mine the effect of purified acrogranin on preimplantation
development, compacted eight-cell mouse embryos were
cultured in the presence of three different concentrations of
acrogranin (0.01, 0.02, and 0.05 mM), medium alone, or the
FIG. 7. Morphology of anti-acrogranin-treated embryos after rem
embryos cultured in medium alone (A) and treated with affinity-pu
removed by washing (A1, B1). At 6 h after the anti-acrogranin w
blastocoel formation was less than that found in control embryo
consisted of healthy blastocysts (B3) but no hatching from the zon
time. However, by 48 h following the removal of anti-acrogranin, th
times; representative images are shown.highest concentration of acrogranin antibody (0.60 mM) for
Copyright © 2000 by Academic Press. All right42 h. Cavitation was scored every 4 h (Fig. 9). Our results
show that the highest concentration of acrogranin (0.05
mM) significantly (P , 0.05) stimulated embryo develop-
ent at each time (84 through 96 h) compared to the other
roups. At 110 h post-hCG, there were no differences in the
ercentages of cavitating embryos among groups treated
ith acrogranin or medium alone. The significant (P , 0.05)
inhibitory effect was corroborated again with embryos
cultured in the presence of anti-acrogranin antibody.
The stimulatory effect of acrogranin on embryo develop-
ment led us to examine if acrogranin reduced the time of
the onset of cavitation, as well as stimulating the rate of
blastocoel expansion. The mean times of cavitation, repre-
senting the point when visible blastocoels had developed in
50% of the final number of blastocysts, were determined. In
eight-cell stage embryos cultured in medium containing the
two different doses of acrogranin (0.02 and 0.05 mM),
of the antibody and subsequent culture. Preimplantation mouse
anti-acrogranin 0.60 mM (B). At 14 h in culture, the antibody was
moved, treated embryos began cavitation (B2) but the extent of
). At 24 h after the antibody was removed, the treatment group
llucidae was apparent; control embryos (A3) were hatching at this
ted embryos had hatched (B4). The experiment was performed fouroval
rified
as re
s (A2
ae pe
e treacavitation progressed more rapidly (95.9 6 0.10 and 95.0 6
s of reproduction in any form reserved.
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414 Dı´az-Cueto et al.0.4 h post hCG, respectively) than in the embryos cultured
in medium alone (97.9 6 0.2 h; Fig. 10). In addition, the
increases in blastocoel volume after 110 h post-hCG with
either the 0.02 or the 0.05 mM dose of acrogranin (23.11 6
1.51 or 23.57 6 2.1 pl, respectively) were statistically
significant (P , 0.05) compared with medium alone (17.9 6
0.86 pl) (Fig. 11).
Purified Acrogranin Stimulates Trophectoderm
Epithelial Cell Proliferation
To determine whether the factor was affecting the prolif-
eration of cells in the embryos, compacted eight-cell em-
bryos were recovered from mated female mice at 68 h
post-hCG. After 24 h in culture (92 h post-hCG), acrogranin
was found to stimulate the proliferation of the trophecto-
derm (P , 0.05; Table 1). Embryos treated with 0.02 or 0.05
mM acrogranin had greater numbers of trophectoderm cells
compared to embryos cultured in medium alone. There
were no statistically significant differences in the numbers
of cells in the ICM between the groups (Table 1). As would
be expected from the increase in the number of trophecto-
derm cells, the total cell number increased significantly
(P , 0.05) in the embryos treated with either dose of
FIG. 8. Inhibition of cell proliferation by anti-acrogranin. Mouse
embryos were cultured from the eight-cell stage through the
blastocyst stage in medium alone, with nonspecific IgG, and with
four different doses of affinity-purified anti-acrogranin antibody.
The embryos were cultured for 47 h and cell numbers per embryo
counted at 115 h post-hCG. The three high concentrations of
acrogranin antibody (0.15, 0.030, and 0.60 mM) significantly
locked the proliferation of blastomeres (P , 0.05) compared with
he controls (medium alone and nonspecific IgG). Shown are
epresentative data from one of two experiments. For each point on
he curve, mean cell numbers per embryo 6 SEM were calculated
or 16–20 embryos in a treatment group. Affinity-purified anti-
crogranin IgG, closed boxes; nonspecific IgG, open diamond.acrogranin.
Copyright © 2000 by Academic Press. All rightDISCUSSION
In this study we provide the first demonstration that
acrogranin expressed by the preimplantation mouse embryo
regulates blastocyst formation in an autocrine manner.
Full-length acrogranin is synthesized and secreted by the
blastocyst. Addition of acrogranin to the culture medium
stimulates the incidence of blastocyst formation, reduces
the time for the onset of cavitation, stimulates the rate of
blastocoel expansion, and increases the number of trophec-
toderm, but not ICM, cells. Moreover, function-blocking
anti-acrogranin antibodies delay the onset of blastocyst
formation.
Acrogranin as an Autocrine Regulator of
Embryonic Development
Acrogranin joins the list of proteins apically secreted by
blastocysts (Dardik and Schultz, 1991b, and references
therein). Secretion of acrogranin into the culture medium is
consistent with its localization in the apical cortices of the
blastomeres; careful examination of the confocal images
suggests that the acrogranin is localized within secretory
granules near the embryo surface. Immunogold electron
microscopy, however, will be required to verify such a
localization. Blastocysts also secrete proteins of both troph-
ectoderm and ICM origin into the blastocoel (Dardik and
Schultz, 1991b). Although the results presented here sug-
gest a role for embryo-derived acrogranin stimulating troph-
ectoderm differentiation, the embryo-derived and -secreted
acrogranin could act as a paracrine regulatory factor on the
endometrium, which is also an epithelium. Reciprocally,
acrogranin is expressed in the uterus (Baba et al., 1993;
Dı´az-Cueto and Gerton, unpublished observations) and
could function as a uterine-derived factor on embryo devel-
opment similar to the way that exogenously added acrogra-
nin accelerated blastocyst formation in culture.
Although acrogranin is detected in ICM cells by immu-
nocytochemistry, a pronounced cortical localization facing
the blastocoel is not observed, suggesting minimal secre-
tion by ICM cells. Analysis of acrogranin secretion by
isolated ICM cells is required to resolve this question. It
should be noted that as development of the embryo pro-
ceeds, the outer cells of the ICM that face the blastocoel
subsequently differentiate into the endoderm, the second
epithelium formed during development. It is tempting to
speculate that if acrogranin is secreted into the blastocoel
by either trophectoderm or ICM cells (or both), the acrogra-
nin could also promote the differentiation of the endoderm
since acrogranin appears to modulate the transformation of
the outer cells of the embryo into the trophectoderm.
The function of acrogranin in the oocyte is not unknown.
Since oocytes secrete proteins that act on the surrounding
follicle cells (Eppig, 1991; Lanuza et al., 1998; Vanderhyden
et al., 1992), it is possible that oocyte-derived acrogranin
could act on the surrounding cumulus cells, which consti-
tute a pseudo-stratified epithelium. Consistent with such a
s of reproduction in any form reserved.
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with the highest expression of acrogranin protein is the
oocyte (Dı´az-Cueto and Gerton, unpublished observations).
Effects of Acrogranin on Differentiation
Acrogranin accelerates the time for the onset of cavita-
tion, as well as stimulating the rate of blastocoel expansion.
Acrogranin could affect the expression of components cen-
tral to these processes. For example, a basolaterally located
Na1/K1-ATPase is responsible for the vectorial transloca-
ion of sodium ions into the blastocoel, and the passive flow
f water in response to the osmotic difference generated
cross the trophectoderm results in expansion of the blas-
ocoel (Biggers et al., 1988). An increase in the expression of
he Na1/K1-ATPase occurs just prior to the onset of cavi-
tation (Watson et al., 1990a,b). Thus, acrogranin could
accelerate the onset of cavitation by up-regulating the
expression of the Na1/K1-ATPase. In a similar vein, an
increase in the Na1/K1-ATPase expression or a change in its
intrinsic activity could result in an increase in the rate of
blastocoel expansion.
Embryos cultured in the presence of anti-acrogranin an-
tibody did not cavitate at the same rate as control embryos.
This effect could result from an inhibition of compaction.
For example, acrogranin could influence tight junction
formation and/or maintenance. The expression of the junc-
tion protein ZO-1a1 appears to be the rate-limiting step in
tight junction formation in the blastocyst (Sheth et al.,
1997). Stimulation of ZO-1a1 expression by acrogranin
FIG. 9. Effect of acrogranin on blastocoel formation in preimp
compacted eight-cell stage through the blastocyst stage in medium
of anti-acrogranin antibody. The embryos were cultured for 42 h and
(0.05 mM) stimulated the development of the embryos in significant
(medium alone). Anti-acrogranin antibody significantly (P , 0.05)
other groups. The data are expressed as means 6 SEM from four ecould stimulate the onset of cavitation, as well as the rate of
Copyright © 2000 by Academic Press. All rightblastocoel expansion, by reducing the paracellular efflux of
small ions from the blastocoel. Acrogranin-induced post-
translational modifications of tight junction proteins could
ation mouse embryos. Mouse embryos were cultured from the
e, in three different doses of acrogranin, and in one concentration
ed for cavitation every 4 h. The highest concentration of acrogranin
(P , 0.05) at each time except at 110 h compared with the control
bited blastocoel formation in treated embryos compared with all
ments with 15–20 embryos per data point for each experiment.
FIG. 10. Exogenously added acrogranin stimulated the onset of
cavitation. Mouse embryos were cultured from the compacted
eight-cell stage through the blastocyst stage in medium alone or in
two doses of acrogranin (0.02 and 0.05 mM). The embryos were
cultured for 42 h and scored for cavitation every 4 h. The mean
time of cavitation represents the time at which 50% of the final
number of blastocysts that cavitated had developed a visible
blastocoel. Both doses of acrogranin showed a stimulatory effect on
the rate of blastocoel expansion and significantly accelerated the
onset of cavitation (P , 0.05) compared with the control. The data
are expressed as the means 6 SEM from five experiments withlant
alon
scor
form15–20 embryos per data point for each experiment.
s of reproduction in any form reserved.
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416 Dı´az-Cueto et al.also result in an increase in tight junction permeability. For
example, an increase in tyrosine phosphorylation is associ-
ated with a decrease in tight junction permeability (Mitic
and Anderson, 1998).
Acrogranin also selectively stimulates the proliferation of
the trophectoderm cells; ICM cell number is unaffected.
This contrasts with the selective stimulation of ICM pro-
liferation in response to insulin and IGFs (Harvey and Kaye,
1992a,b), which is likely attributed to their being transcy-
tosed across the trophectoderm, so that they can bind to
their cognate receptors that are expressed on the ICM
(Heyner et al., 1989; Smith et al., 1993). The ability of
acrogranin to stimulate cell proliferation in isolated ICMs
is not known. Similar to acrogranin, the cytokine colony-
stimulating factor-1 (CSF-1) also accelerates the onset of
cavitation and selectively increases the number of trophec-
FIG. 11. Acrogranin accelerated the expansion of the blastocoelic
avity in treated embryos. Mouse embryos were cultured from
ompacted eight-cell stage through the blastocyst stage in medium
lone and medium containing two different doses of acrogranin
0.02 and 0.05 mM). After 110 h post-hCG both doses of acrogranin
stimulated blastocoel expansion. The difference between the con-
trol and both doses of acrogranin was significant (P , 0.05). The
data are expressed as the means 6 SEM from two experiments with
5–20 embryos per data point for each experiment.
ABLE 1
ell Numbers in Blastocysts 24 h after Acrogranin Added to the C
Blastocysts
examined Inne
Medium 42 15.
Acrogranin (0.02 mM) 31 18.
Acrogranin (0.05 mM) 30 16.
Note. Values represent the means 6 SEM of the data derived fro
a,b P , 0.05 medium vs acrogranin 0.02 and 0.05 mM.
Copyright © 2000 by Academic Press. All righttoderm cells (Bhatnagar et al., 1995); however, the effect of
CSF-1 on the rate of blastocoel expansion was not analyzed
in that study. TGF-a/EGF also promotes an increase in the
ate of blastocoel expansion. The ability of several different
mbryo-derived factors to modulate a similar set of auto-
rine responses constitutes an example of compensatory
echanisms functioning during preimplantation develop-
ent, and the results presented here add acrogranin to the
ist of such factors.
Acrogranin Effects on Embryo Differentiation in
Relation to Other Studies
Several studies have identified acrogranin or fragments of
acrogranin (e.g., epithelins, granulins, TGFe) as factors
containing growth-modulatory activity principally toward
epithelial cells. In fact, the original identification of the
;6000 Mr epithelins as growth factors, followed by the
ecognition that the primary structure of acrogranin encom-
asses the amino acid sequences of all epithelins and
ranulins, led some to speculate that acrogranin is an
nactive precursor for the smaller peptides. Recently, it has
ecome clear that the full-length protein is bioactive and
ay be more potent than the smaller peptides. For example,
he full-length protein is an autocrine growth factor for PC
ells and R cells. The PC cell line is a highly tumorigenic,
nsulin-independent, teratoma-derived cell line isolated
rom the nontumorigenic, insulin-dependent 1246 cell line
Zhou et al., 1993). Acrogranin is the only purified growth
actor known to stimulate the growth of R2 cells, mouse
mbryo fibroblasts null for the type 1 insulin-like growth
actor receptor (Xu et al., 1998). Results presented in our
tudies demonstrate that blastocysts secrete a full-length
orm of acrogranin and that it is most likely that this form
cts directly on the trophectoderm cells of preimplantation
ouse embryos in an autocrine manner.
The fact that embryos elicit responses to acrogranin
ndicates that they possess the necessary machinery to bind
he factor and trigger an intracellular signal transduction
athway. The signaling mechanisms elicited in response to
crogranin action are gradually being elucidated. Recently,
he epithelin/granulin precursor (i.e., acrogranin) has been
hown to activate two mitogenic signaling pathways in the
re and 92 h Post-hCG
l mass Trophectoderm
Total cells per
blastocyst
0.67 26.04 6 1.03a 41.71 6 1.18b
0.86 31.51 6 1.10 49.51 6 1.52
0.88 30.10 6 1.19 46.73 6 1.48
e number of blastocysts analyzed in each group.ultu
r cel
80 6
06 6
60 6
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417Preimplantation Embryo Development and AcrograninIGF-I receptor-deficient R2 cells, the mitogen-activated
rotein kinase and phosphatidylinositol 3-kinase pathways
Zanocco-Marani et al., 1999). However, very little is
nown about the acrogranin receptor. It has been detected
y binding assays but the acrogranin receptor appears to be
istinct from any other known cytokine or growth factor
eceptor (Culouscou et al., 1993; Parnell et al., 1995; Xia
nd Serrero, 1998). Localization of the acrogranin receptor
n the blastocyst, which could afford insights regarding
crogranin action on trophectoderm and ICM cells, awaits
ts molecular identification and characterization.
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